- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02137135
Menstrual Phase and Postoperative Pain
May 12, 2014 updated by: SINEM SARI, Aydin Adnan Menderes University
The Influence of the Menstrual Cycle on Acute and Persistent Pain After Laparoscopic Cholecystectomy
Fluctuations of female sex hormones during the menstrual cycle influence pain perception.
Endogenous pain is pronounced in the follicular phase of the menstrual cycle.
The investigators tested the primary hypothesis that the women having surgery during their follicular phase have more acute pain and require more opioids than those in the luteal phase, and secondarily the investigators tested that women who have surgery during their follicular phase have more incisional pain at 3 month postoperatively.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
127 adult females having laparoscopic cholecystectomy were randomized to have surgery during the luteal or follicular phase of their menstrual cycle.
Standardized anesthesia and pain management regimen was given to all patients.
Pain and analgesic consumption were evaluated in PACU and every four hours in first 24 hours.
Adverse effects were also questioned every four hours.
Time to oral intake and ambulation were recorded.
Post-surgical pain, hospital anxiety and depression scale, and SF-12 questionnaire were also evaluated at 1- and 3-month visits.
Study Type
Interventional
Enrollment (Actual)
64
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aydin, Turkey, 09100
- Adnan Menderes University Medical Faculty, Anesthesiology and Reanimation Department
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women with a negative urine pregnancy test
Exclusion Criteria:
- Patients with pre-existing pain syndromes
- Patients using routinely using opioids
- Patients using hormone preparations in the last 6 months
- Patients with hysterectomy
- Patients breastfeeding in the previous 6 months
- Patients with body mass index >35 kg/m2
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: follicular phase
Visual anlogue score vas used to evaluate pain.
The anxiety/depression scale (HAD) was used to assess anxiety and depression.
The SF 12 test (SHORT FORM 12) was used to evaluate quality of life.
|
The anxiety/depression scale (HAD) was used to assess anxiety and depression.
Other Names:
The SF 12 test (SHORT FORM 12) was used to evaluate quality of life.
Other Names:
Visual analogue score vas used to evaluate pain.
Other Names:
|
Active Comparator: luteal phase
Visual anlogue score vas used to evaluate pain.
The anxiety/depression scale (HAD) was used to assess anxiety and depression.
The SF 12 test (SHORT FORM 12) was used to evaluate quality of life.
|
The anxiety/depression scale (HAD) was used to assess anxiety and depression.
Other Names:
The SF 12 test (SHORT FORM 12) was used to evaluate quality of life.
Other Names:
Visual analogue score vas used to evaluate pain.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Persistent surgical pain after laparoscopic cholecystectomy assessed by VAS scale
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The anxiety and depression was evaluated with Hospital anxiety and depression scale.
Time Frame: 3 months
|
3 months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Quality of life was evaluated with SF 12 test.
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Betul Kozanhan, Specialist Doctor, Konya Education and Research Hospital, Anesthesiology and Reanimation Department, Konya; Turkey
- Principal Investigator: Ayse Ilksen Egilmez, Specialist Doctor, Konya Education and Research Hospital, Anesthesiology and Reanimation Department, Konya; Turkey
- Principal Investigator: Aykut Soyder, Assistant Professor, Adnan Menderes University Medical Faculty, General Surgery Department, Aydin; Turkey
- Principal Investigator: Fabrizio Galimberti, Medical Student, Cleveland ClinicLernerCollege of Medicine, Cleveland, Ohio
- Principal Investigator: Daniel I. Sessler, Professor and Ch, Department of Outcomes Research, Cleveland Clinic
- Principal Investigator: Alparslan Turan, Associate Professor, Associate Professor of Anesthesiology, Department of Outcomes Research, Cleveland Clinic
- Principal Investigator: Osman Nuri Aydın, Professor, Adnan Menderes University Medical Faculty, Anesthesiology and Reanimation Department, Aydin; Turkey
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2012
Primary Completion (Actual)
November 1, 2013
Study Completion (Actual)
November 1, 2013
Study Registration Dates
First Submitted
May 12, 2014
First Submitted That Met QC Criteria
May 12, 2014
First Posted (Estimate)
May 13, 2014
Study Record Updates
Last Update Posted (Estimate)
May 13, 2014
Last Update Submitted That Met QC Criteria
May 12, 2014
Last Verified
May 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SARI-05
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Postoperative Pain
-
Schulthess KlinikNot yet recruiting
-
Seoul National University HospitalNot yet recruiting
-
Chung-Ang University Gwangmyeong HospitalRecruitingPostoperative Pain, AcuteKorea, Republic of
-
TC Erciyes UniversityCompletedPostoperative Pain, AcuteTurkey
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Ankara City Hospital BilkentRecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | SternotomyTurkey
-
Umraniye Education and Research HospitalNot yet recruiting
-
Sohag UniversityCompletedPostoperative Pain, AcuteEgypt
-
Rajavithi HospitalCompletedTotal Abdominal Hysterectomy ,Pain , Acute Postoperative,Gabapentin , CelecoxibThailand
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
Clinical Trials on HAD scale
-
Institut de Cancérologie de la LoireCompleted
-
Université Catholique de LouvainActive, not recruiting
-
University Hospital, BordeauxActive, not recruitingPain | Peripheral NeuropathyFrance
-
Queen's UniversityUnknownIrritable Bowel Syndrome | Visceral HypersensitivityCanada
-
Aydin Adnan Menderes UniversityCompletedAcute Postoperative Pain | Chronic Postoperative PainTurkey
-
University Hospital, MontpellierAix Marseille Université; La Conception Hospital - Marseille - France; Public...CompletedPatients Presenting Essure Device Attributed SymptomsFrance
-
Rennes University HospitalInstitut NuMeCan, INRAE 1341Completed
-
West China HospitalRecruiting
-
University Hospital, BrestCompletedEndodontic TreatmentFrance
-
NYU Langone HealthWithdrawn